Molecular and Cellular Mechanism in Rhinitis Allergic Patients Treated With GRAZAX®
Clinical trial NCT02437786 · COMPLETED
Trial details
- NCT number
- NCT02437786
- Sponsor
- ALK-Abelló A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-09-01
- Primary completion
- 2014-12-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.